Kamada (KMDA) Receivables - Other (2012 - 2026)
Kamada (KMDA) posted quarterly Receivables - Other of $4.1 million for Q1 2026, down 31.25% year-on-year from $6.0 million in Q1 2025, and down 26.87% on a QoQ basis from $5.7 million in Q4 2025.
Kamada (KMDA) Receivables - Other (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Receivables - Other for 15 consecutive years, with $4.1 million the latest figure, recorded in Q1 2026.
- Quarterly Receivables - Other fell 31.25% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (down 31.25% YoY) and the FY2025 annual result came in at $5.7 million, up 1.98% from the prior year.
- Receivables - Other retreated to $4.1 million in Q1 2026 per KMDA's latest filing, from $5.7 million in the prior quarter.
- Over the last five years, Receivables - Other for KMDA reached as high as $7.9 million in Q1 2022 and fell as low as $3603.0 in Q1 2023.
- A 5-year average of $4.2 million and a median of $4.7 million in 2025 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2023 — Receivables - Other slumped 99.95% — and 2024, when it surged 177835.05%.
- Year by year, Receivables - Other stood at $544000.0 in 2022, then jumped by 996.51% to $6.0 million in 2023, then decreased by 7.02% to $5.5 million in 2024, then advanced by 1.98% to $5.7 million in 2025, then fell by 26.87% to $4.1 million in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $4.1 million, $5.7 million, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.14 Mn |
| Mar 31, 2026 | 4.14 Mn |
| Dec 31, 2025 | 5.66 Mn |
| Dec 31, 2025 | 5.66 Mn |
| Sep 30, 2025 | 3.95 Mn |
| Sep 30, 2025 | 3.95 Mn |
| Jun 30, 2025 | 4.70 Mn |
| Jun 30, 2025 | 4.70 Mn |
| Mar 31, 2025 | 6.02 Mn |
| Mar 31, 2025 | 6.02 Mn |
| Dec 31, 2024 | 5.55 Mn |
| Dec 31, 2024 | 5.55 Mn |
| Sep 30, 2024 | 4.56 Mn |
| Sep 30, 2024 | 4.56 Mn |
| Jun 30, 2024 | 4.94 Mn |
| Jun 30, 2024 | 4.94 Mn |
| Mar 31, 2024 | 6.41 Mn |
| Mar 31, 2024 | 6.41 Mn |
| Dec 31, 2023 | 5.97 Mn |
| Dec 31, 2023 | 5.97 Mn |